[ad_1]
The Food and Drug Administration has approved a topical wipe that can help reduce excessive underarm sweating, the company behind the product said Friday.
Qbrexza is a fabric that can be applied daily to the skin to reduce perspiration by blocking perspiration. activation of the gland, according to an announcement from the manufacturer Dermira. The product offers a subtle solution to the millions of people who suffer from primary focal axillary hyperhidrosis, or excessive underarm sweating, which is currently often treated with Botox and other more invasive options.
In two clinical trials, Qbrexza showed to reduce According to Dermira, sweat production of patients and their severity. Possible side effects include dryness of the skin, mouth, eyes, nose and throat; irritated throat; headache; blurred vision and dilated pupils; and constipation and problems with urinating.
The product is approved for patients nine years of age and older, and is expected to hit pharmacies in October, according to the announcement. Dermira did not disclose price information.
Source link
